fig3

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Figure 3. An overview of epidemiological evidence (studies published before 2015) linking raised GGT values with cardiovascular events and mortality[57].